Patents by Inventor Roumen Balabanov

Roumen Balabanov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA methylation based test for monitoring efficacy of treatment
    Patent number: 8497066
    Abstract: A DNA methylation-based test for efficiency of treatments is based on a plurality of genes. The test is suitable for monitoring treatment of subjects with neurological diseases, e.g., multiple sclerosis (MS); with cancer, e.g., breast and ovarian cancer, and with other diseases for which methylation of biomarkers differs in the diseased compared to the non-diseased state.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: July 30, 2013
    Assignee: Rush University Medical Center
    Inventors: Victor Levenson, Anatoliy Melnikov, Roumen Balabanov, Dusan Stefoski
  • DNA METHYLATION BASED TEST FOR MONITORING EFFICACY OF TREATMENT
    Publication number: 20100143929
    Abstract: A DNA methylation-based test for efficiency of treatments is based on a plurality of genes. The test is suitable for monitoring treatment of subjects with neurological diseases, e.g., multiple sclerosis (MS); with cancer, e.g., breast and ovarian cancer, and with other diseases for which methylation of biomarkers differs in the diseased compared to the non-diseased state.
    Type: Application
    Filed: December 4, 2009
    Publication date: June 10, 2010
    Applicant: RUSH UNIVERSITY MEDICAL CENTER
    Inventors: Victor Levenson, Anatoliy Melnikov, Roumen Balabanov, Dusan Stefoski
  • DIFFERENTIAL LABELING OF CELLS
    Publication number: 20080109914
    Abstract: The invention relates to the generation of an animal model that exhibits neural cell-specific expression of a marker gene that correlates to remyelination or myelin repair. The compositions and methods embodied in the present invention are particularly useful for drug screening and/or treatment of demyelination disorders, particularly in identifying compounds that promote or inhibit remyelination.
    Type: Application
    Filed: August 10, 2007
    Publication date: May 8, 2008
    Inventors: Brian Popko, Roumen Balabanov, Trent Watkins